MICHAEL SWOPE: Open Payments
NPI 1184326787 · PRINCETON, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 40 payments from 14 companies in 2025. Trend: 2023 $415 · 2024 $533 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 7 | $153 |
| AstraZeneca Pharmaceuticals LP | 6 | $137 |
| PFIZER INC. | 6 | $106 |
| Novo Nordisk Inc | 4 | $65 |
| Exact Sciences Corporation | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $38 |
| Astellas Pharma US Inc | 1 | $25 |
Products named: REXULTI, FARXIGA, ELIQUIS, ROTATEQ, Cologuard Collection Kit, AUSTEDO XR, MOUNJARO, Rybelsus.
Industry payments across ME — which companies pay providers there.
